Development and management of extrapyramidal symptoms in hypertensive patients treated with diazoxide.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001007:Anxiety; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy; D003981:Diazoxide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D000978:Antiparkinson Agents; D003981:Diazoxide